RecruitingNot ApplicableNCT06576908

Evaluation of On-Couch CBCT Image Quality

Evaluation of Image Quality From an On-Couch, Cone Beam Computed Tomography (CBCT) Radiation Treatment System for Image Guidance and Treatment Adaptation

Sponsor

Varian, a Siemens Healthineers Company

Enrollment

46 participants

Start Date

Oct 17, 2024

Study Type

INTERVENTIONAL

Conditions

Head and Neck Cancer Thoracic Cancer Abdominal Cancer Pelvic Cancer

Summary

This is a prospective, single-arm, single-site study designed to generate data describing the image quality and applicability/useability of a high-performance, on-couch CBCT imaging technology (HyperSight) in patients receiving radiation treatment for cancer on a C-arm linear accelerator (TrueBeam).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating the quality of CT scan images taken during radiation therapy (on-couch CBCT) to help improve how doctors see and target tumors more accurately during treatment. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with primary or metastatic cancer affecting areas like the head/neck, lungs, liver, pancreas, prostate, bladder, rectum, or uterus - Your doctor has already decided you need radiation therapy using a specific radiation machine (Varian TrueBeam) **You may NOT be eligible if...** - You are not scheduled for radiation therapy with the required equipment - You are unable to consent to participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHyperSight Imaging

Subjects receive both HyperSight imaging and conventional imaging, on their first day of radiation treatment, on their second day of treatment, and on their last day of treatment.